Literature DB >> 23235663

Psychosocial interventions for reducing antipsychotic medication in care home residents.

Tanja Richter1, Gabriele Meyer, Ralph Möhler, Sascha Köpke.   

Abstract

BACKGROUND: Antipsychotic medication is regularly prescribed in care homes to control 'behavioural and psychological symptoms of dementia' despite moderate efficacy, significant adverse effects, and available non-pharmacological alternatives.
OBJECTIVES: To evaluate the effectiveness of psychosocial interventions to reduce antipsychotic medication in care home residents. SEARCH
METHODS: The Cochrane Dementia and Cognitive Improvement Group's Specialized Register, MEDLINE, EMBASE, CINAHL, PsycINFO, LILACS, a number of trial registers and grey literature sources were searched on 19th December 2011. SELECTION CRITERIA: Individual or cluster-randomised controlled trials comparing a psychosocial intervention aimed at reducing antipsychotic medication with usual care in care home residents or comparing two different approaches. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed the retrieved articles for relevance and methodological quality and extracted data. Critical appraisal of studies addressed risk of bias through selection bias, performance bias, attrition bias, and detection bias, as well as criteria related to cluster design. Authors of relevant studies were contacted for additional information.Owing to clinical heterogeneity of interventions, statistical heterogeneity was not assessed and no meta-analysis performed. Study results are presented in a narrative form. MAIN
RESULTS: Four cluster-randomised controlled studies met the inclusion criteria. All of them investigated complex interventions comprising educational approaches. Three studies offered education and training for nursing staff, one study offered multidisciplinary team meetings as main component of the intervention. There was one high-quality study, but overall the methodological quality of studies was moderate. The studies revealed consistent results for the primary end point. All studies documented a decrease of the proportion of residents with antipsychotic drug use or a reduction in days with antipsychotic use per 100 days per resident, respectively. In summary, the reviewed evidence on psychosocial interventions targeting professionals is consistent with a reduction of antipsychotic medication prescription in care home residents. However, owing to heterogeneous approaches, summary effect sizes cannot be determined. AUTHORS'
CONCLUSIONS: There is evidence to support the effectiveness of psychosocial interventions for reducing antipsychotic medication in care home residents. However, the review was based on a small number of heterogeneous studies with important methodological shortcomings. The most recent and methodologically most rigorous study showed the most pronounced effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235663      PMCID: PMC6492452          DOI: 10.1002/14651858.CD008634.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  63 in total

1.  Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes.

Authors:  M S Roberts; J A Stokes; M A King; T A Lynne; D M Purdie; P P Glasziou; D A Wilson; S T McCarthy; G E Brooks; F J de Looze; C B Del Mar
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

2.  Mood and general behavior of patients with severe dementia during one year of supervised, individualized planned care and systematic clinical supervision. Comparison with a similar control group.

Authors:  A K Edberg; A Norberg; I R Hallberg
Journal:  Aging (Milano)       Date:  1999-12

3.  Influence of facility characteristics on use of antipsychotic medications in nursing homes.

Authors:  C M Hughes; K L Lapane; V Mor
Journal:  Med Care       Date:  2000-12       Impact factor: 2.983

4.  Guidelines for the management of agitation in dementia.

Authors:  R Howard; C Ballard; J O'Brien; A Burns
Journal:  Int J Geriatr Psychiatry       Date:  2001-07       Impact factor: 3.485

5.  Variations in the treatment culture of nursing homes and responses to regulations to reduce drug use.

Authors:  B L Svarstad; J K Mount; W Bigelow
Journal:  Psychiatr Serv       Date:  2001-05       Impact factor: 3.084

6.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

7.  Effects of a pharmacist's medication review in nursing homes. Randomised controlled trial.

Authors:  L Furniss; A Burns; S K Craig; S Scobie; J Cooke; B Faragher
Journal:  Br J Psychiatry       Date:  2000-06       Impact factor: 9.319

Review 8.  Psychosocial interventions for individuals with dementia: an integration of theory, therapy, and a clinical understanding of dementia.

Authors:  J Kasl-Godley; M Gatz
Journal:  Clin Psychol Rev       Date:  2000-08

9.  Prevalence of dementia in institutional care.

Authors:  Fiona E Matthews; Tom Dening
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

10.  No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients.

Authors:  Myron F Weiner; Rochelle E Tractenberg; Mary Sano; Rebecca Logsdon; Linda Teri; Douglas Galasko; Anthony Gamst; Ron Thomas; Leon J Thal
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

View more
  24 in total

1.  Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study.

Authors:  Eva Mann; Burkhard Haastert; Birgit Böhmdorfer; Thomas Frühwald; Bernhard Iglseder; Regina Roller-Wirnsberger; Gabriele Meyer
Journal:  Wien Klin Wochenschr       Date:  2013-03-28       Impact factor: 1.704

Review 2.  Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

Authors:  Mairead McGrattan; Cristín Ryan; Heather E Barry; Carmel M Hughes
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 3.  Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Authors:  Marta Miarons; Christopher Cabib; Francisco Javier Barón; Laia Rofes
Journal:  Eur J Clin Pharmacol       Date:  2017-08-05       Impact factor: 2.953

4.  [Interventions to optimise prescribing for older people in care homes].

Authors:  Sebastian Voigt-Radloff; Claudia Bollig; Gabriel Torbahn; Michael Denkinger; Jürgen Bauer
Journal:  Z Gerontol Geriatr       Date:  2020-02       Impact factor: 1.281

Review 5.  Alzheimer's disease and nursing homes.

Authors:  Joseph E Gaugler; Fang Yu; Heather W Davila; Tetyana Shippee
Journal:  Health Aff (Millwood)       Date:  2014-04       Impact factor: 6.301

6.  Informed Family Member Involvement to Improve the Quality of Dementia Care in Nursing Homes.

Authors:  Jennifer Tjia; Celeste A Lemay; Alice Bonner; Christina Compher; Kelli Paice; Terry Field; Kathleen Mazor; Jacob N Hunnicutt; Kate L Lapane; Jerry Gurwitz
Journal:  J Am Geriatr Soc       Date:  2016-08-22       Impact factor: 5.562

Review 7.  Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review.

Authors:  Daniel J Hoyle; Ivan K Bindoff; Lisa M Clinnick; Gregory M Peterson; Juanita L Westbury
Journal:  Drugs Aging       Date:  2018-02       Impact factor: 3.923

8.  Testing the evidence integration triangle for implementation of interventions to manage behavioral and psychological symptoms associated with dementia: Protocol for a pragmatic trial.

Authors:  Barbara Resnick; Ann Kolanowski; Kimberly Van Haitsma; Elizabeth Galik; Marie Boltz; Jeanette Ellis; Liza Behrens; Nina M Flanagan; Karen J Eshraghi; Shijun Zhu
Journal:  Res Nurs Health       Date:  2018-02-27       Impact factor: 2.228

9.  Nonpharmacologic treatment of behavioral disorders in dementia.

Authors:  Jiska Cohen-Mansfield
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

10.  Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.

Authors:  Maria Soto; Sandrine Andrieu; Fati Nourhashemi; Pierre Jean Ousset; Clive Ballard; Philippe Robert; Bruno Vellas; Constantine G Lyketsos; Paul B Rosenberg
Journal:  Int Psychogeriatr       Date:  2014-09-16       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.